| Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival SD Brown, RL Warren, EA Gibb, SD Martin, JJ Spinelli, BH Nelson, ... Genome research 24 (5), 743-750, 2014 | 671 | 2014 |
| Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer NR West, SE Kost, SD Martin, K Milne, RJ Deleeuw, BH Nelson, ... British journal of cancer 108 (1), 155-162, 2013 | 306 | 2013 |
| Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer DA Wick, JR Webb, JS Nielsen, SD Martin, DR Kroeger, K Milne, ... Clinical Cancer Research 20 (5), 1125-1134, 2014 | 171 | 2014 |
| Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines SD Martin, SD Brown, DA Wick, JS Nielsen, DR Kroeger, ... PLOS ONE 11 (5), e0155189, 2016 | 140 | 2016 |
| Combined immunodeficiency associated with homozygous MALT1 mutations TSE McKinnon ML, Rozmus J, Fung SY, Hirschfeld AF, Del Bel KL, Thomas L ... Journal of Allergy and Clinical Immunology 133 (5), 1458-62, 2014 | 128 | 2014 |
| Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era SD Martin, G Coukos, RA Holt, BH Nelson Annals of oncology 26 (12), 2367-2374, 2015 | 67 | 2015 |
| Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly (I: C) DA Wick, SD Martin, BH Nelson, JR Webb Vaccine 29 (5), 984-993, 2011 | 65 | 2011 |
| Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence KSS Enfield, SD Martin, EA Marshall, SHY Kung, P Gallagher, K Milne, ... Journal for immunotherapy of cancer 7 (1), 1-13, 2019 | 48 | 2019 |
| Single-cell genomic variation induced by mutational processes in cancer T Funnell, CH O’Flanagan, MJ Williams, A McPherson, S McKinney, ... Nature 612 (7938), 106-115, 2022 | 47 | 2022 |
| A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer SD Martin, DA Wick, JS Nielsen, N Little, RA Holt, BH Nelson Oncoimmunology 7 (1), e1371895, 2018 | 42 | 2018 |
| Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma JS Nielsen, AR Chang, DA Wick, CG Sedgwick, Z Zong, AJ Mungall, ... Oncoimmunology 6 (7), e1321184, 2017 | 25 | 2017 |
| Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response AP Sage, KW Ng, EA Marshall, GL Stewart, BC Minatel, KSS Enfield, ... Scientific reports 10 (1), 16945, 2020 | 22 | 2020 |
| Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma KW Ng, EA Marshall, KSS Enfield, SD Martin, K Milne, ME Pewarchuk, ... Oncoimmunology 7 (12), e1504728, 2018 | 22 | 2018 |
| Immunohistochemical demonstration of Merlin/NF2 loss in mesothelioma SD Martin, S Cheung, A Churg Modern Pathology 36 (1), 2023 | 5 | 2023 |
| Ma24. 06 long non-coding rna expression patterns delineate infiltrating immune cells in the lung tumour microenvironment A Sage, K Ng, E Marshall, K Enfield, G Stewart, S Martin, B Minatel, ... Journal of Thoracic Oncology 13 (10), S443-S444, 2018 | 5 | 2018 |
| Biomarkers for immune checkpoint inhibitors in renal cell carcinoma SD Martin, I Bhuiyan, M Soleimani, G Wang Journal of Clinical Medicine 12 (15), 4987, 2023 | 4 | 2023 |
| Indicators differentiating thrombotic thrombocytopenic purpura from other thrombotic microangiopathies in a canadian apheresis referral center SD Martin, E McGinnis, TW Smith American Journal of Clinical Pathology 156 (6), 1103-1112, 2021 | 3 | 2021 |
| Personalized Immunotherapy Targeting the Cancer Mutanome JS Nielsen, SD Martin, N Brad H Encyclopedia of Immunobiology 4 (doi:10.1016/B978-0-12-374279-7.1), 426-433, 2016 | 3 | 2016 |
| PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi SD Martin, KC Martin, CB Gilks, RI Crawford, LN Hoang International Journal of Gynecological Pathology, 10.1097, 2023 | 1 | 2023 |
| Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers A Jamieson, J Sobral de Barros, DR Cochrane, JM Douglas, S Shankar, ... Clinical Cancer Research, 2024 | | 2024 |
Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyVerified email at bccancer.bc.ca
